[HTML][HTML] Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
F Vincenti, S Friman, E Scheuermann… - American Journal of …, 2007 - Elsevier
DIRECT (Diabetes Incidence after Renal Transplantation: Neoral C 2 Monitoring Versus
Tacrolimus) was a 6-month, open-label, randomized, multicenter study which used
American Diabetes Association/World Health Organization criteria to define glucose
abnormalities. De novorenal transplant patients were randomized to cyclosporine
microemulsion (CsA-ME, using C 2 monitoring) or tacrolimus, with mycophenolic acid,
steroids and basiliximab. The intent-to-treat population comprised 682 patients (336 CsA …
Tacrolimus) was a 6-month, open-label, randomized, multicenter study which used
American Diabetes Association/World Health Organization criteria to define glucose
abnormalities. De novorenal transplant patients were randomized to cyclosporine
microemulsion (CsA-ME, using C 2 monitoring) or tacrolimus, with mycophenolic acid,
steroids and basiliximab. The intent-to-treat population comprised 682 patients (336 CsA …